Leishmania Recidivans Could Be Induced by Intralesional Infiltration of Cutaneous Leishmaniasis by Sodium Stibogluconate, with New Therapeutic Trial

نویسندگان

چکیده

Objective: Leishmania recidivans is a chronic form of cutaneous leishmaniasis with characteristic picture. So the aim this study to record all cases leishmania that had history therapy by sodium stibogluconate. Patients and methods: This case series descriptive interventional therapeutic. Twenty-two patients clinical picture were included. All gave 2-4-month duration before time therapeutic injection They treated intralesional injections stibogluconate for several times every two weeks months years present presentation examination. combination oral ketoconazole, zinc sulfate topical 15-25% podophyllin around 1-2 months. Results: evaluated, their ages ranged from 1-20 median 10 years, 16 (72.72%) males 6 (27.27%) females. The location lesions was mostly on face upper limbs. On examination, there ill-defined plaques clearing at centers leaving some atrophy scarring while active dusky red papules nodules periphery primary lesion. response regime obvious after three marked one month almost complete clearance 2 Conclusions: work showed new explanation evolution as induced recidivans. Oral ketoconazole combined are effective modes treatment

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

The Evaluation of Intralesional Glucantime and Cryotherapy plus Intralesional Glucantime Therapeutic Efficacy on Zoonotic Cutaneous Leishmaniasis: A Randomized Clinical Trial

Background: Currently, Glucantime is considered the first-line treatment of cutaneous Leishmaniasis. This study aimed to evaluation of intralesional Glucantime (IG) and Cryotherapy (Cryo) plus intralesional Glucantime (Cryo and IG) therapeutic efficacy on Zoonotic Cutaneous Leishmaniasis in Qom province, Iran. Materials and Methods: In this randomized controlled trial of 197 CL patients reporte...

متن کامل

Sodium Stibogluconate: Therapeutic use in the Management of Leishmaniasis

Leishmaniasis causes significant morbidity and mortality worldwide. The disease is endemic in developing countries of tropical regions, and in recent years economic globalization and increased travel has also spread to people in developed countries. In the absence of effective vaccines and vector-control measures, the main line of defense against the disease is chemotherapy. Organic pentavalent...

متن کامل

Cutaneous Leishmaniasis Caused by Leishmania killicki, Algeria

Streptococcus suis serotypes characterized by analysis of chaperonin 60 gene sequences. Use of polyvalent coagglutination re-agents for serotyping of Streptococcus suis. 14 new capsular types of Streptococcus suis. Cutaneous Leishmaniasis Caused by Leishmania killicki, Algeria To the Editor: Cutaneous leish-maniasis (CL) is a widespread and resurging vector-borne disease caused by a protozoan p...

متن کامل

HIV-1 replication is stimulated by sodium stibogluconate, the therapeutic mainstay in the treatment of leishmaniasis.

Leishmaniasis is an important opportunistic disease among patients infected with human immunodeficiency virus (HIV)-1. The pentavalent antimony compound sodium stibogluconate is a drug of choice for the treatment of leishmaniasis. Because sodium stibogluconate acts as an inhibitor of phosphotyrosyl phosphatases and such inhibitors can promote HIV-1 replication, we tested the effect of this comp...

متن کامل

Immunization Against Cutaneous Leishmaniasis by Alginate Microspheres Loaded With Autoclaved Leishmania Major (ALM) and Quillaja Saponins

Leishmania antigens are weak immunogens and need to be potentiated by various adjuvants and delivery systems. Alginate microspheres as an antigen delivery system and Quillaja saponins (QS) as an immunoadjuvant have been used to enhance the immune response against Autoclaved Leishmania major (ALM). Microspheres were prepared by an emulsification technique and characterized for size, encapsulatio...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Journal of Clinical and Experimental Investigations

سال: 2022

ISSN: ['1309-8578', '1309-6621']

DOI: https://doi.org/10.29333/jcei/11516